We invest in early-stage life-science companies with the potential to enhance human well-being and quality of life.
Continuing to
Grow & Invest
We are an evergreen fund that has a long-term investment perspective.
Focusing on the
Mid-Atlantic Region
We invest in life-science companies in the Mid-Atlantic region.
Launching Successful
Companies
Our portfolio companies have attracted over $4.4 billion of external capital to support their growth.
Latest News
AllAccelerated BiosciencesAcuity PharmaceuticalsAlleviAlterisAnnovisAtalanAvid RadiopharmaceuticalsBainbridge HealthBioAdvance NewsCeptarisCohero HealthConcarlo TherapeuticsCrossBridgeEliksa TherapeuticsENB TherapeuticsGeneralHalo LabsHanimune TherapeuticsHealthQxHueDxImmunoGenesisImmunomeInfraScanInnervaceIntezyneiView TherapeuticsKaloCyteKayotheraKeritonLatusLumenVuMebias DiscoveryMelior DiscoveryMidway PharmaceuticalsNovira TherapeuticsNuPatheOncora MedicalOnspira TherapeuticsOpsidioOssianixPalvella TherapeuticsPhrase HealthPillo HealthPortfolio NewsProtez PharmaceuticalsPSTRelmada TherapeuticsRenovacorRide HealthSenzoSIRPantStradosThe One Health CompanyTolerance BioTreventis CorporationVenatorx PharmaceuticalsVesteckVittoria BiotherapeuticsWellsheet
Keriton Announces Acquisition by Natus Sensory to Accelerate Adoption of Its Feeding Management Platform
Keriton Announces Acquisition by Natus Sensory to Accelerate Adoption of Its Feeding Management Platform
Strados Labs Announces Study Evaluating Remote Lung Sound Monitoring to Predict COPD Exacerbations
Strados Labs Announces Study Evaluating Remote Lung Sound Monitoring to Predict COPD Exacerbations
IVIEW Therapeutics’ Innovative Gene Therapy GVB-2001 Treats First Primary Open-Angle Glaucoma Patient
IVIEW Therapeutics’ Innovative Gene Therapy GVB-2001 Treats First Primary Open-Angle Glaucoma Patient
Insmed Provides Clinical and Business Update